.
Two questions which anyone here might be able to answer:---
1 After installation of the new TAVR, what happens to the scrunched-up remnant of the existing natural valve? .... assuming the "parachute strings" can be cut away (or left in place anyone know?) surely the remnant becomes a source for the post-installation growth of nasties? This remnant of the natural valve left in place seems like it is not a very elegant total design solution to the problem.
.
2 Currently after installation of the new valve, whichever brand it is, the patient has to take daily blood thinners for the rest of his/her life with all the cost and nuiscance this entails. If our valve has better flow characteristics does this result in a lower possiblity of clotting and hence reduced post-op medication? Is there any way of predicting the likelihood of clotting from test measuring the valve characteristics?
thanks
.
TAVR presented at #JPM2020 by CEO, page-19
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.60 | $347.8K | 23.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 760 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.15 | 388 | 1 |
View Market Depth
| Last trade - 15.58pm 30/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |